Bagian Obstetri dan Ginekologi RSU. Dr. Soetomo Surabaya DAMPAK ANEMIA TERHADAP KEHAMILAN, PERSALINAN DAN OUTCOME PERINATAL DEFINISI ANEMIA REKOMENDASI WHO
1. Non Pregnant - Hb. < 12.0 g/dl. 2. Pregnant - Hb. < 11.0 g/dl 3. Post partum Hb. < 10 g/dl AKIBAT ANEMIA Penurunan kapasitas transport O2 Risiko terjadinya hipoksia jaringan Gangguan daro fungsi organ dan metabolisme (O2 dependent metab.) ADAPTASI Peningkatan Cardiac Output (Heart Rate) Hypoxia Induce Vasodilatation Peningkatan perfusi jaringan Redistribusi darah pada organ vital Peningkatan Resp. Minute Volume Peningkatan A-V O2 Gradient Erythropoetin Release Pregnancy related chages in maternal blood volume (L) Total Blood, Plasma and Erythrocyte Value ( From Longo LD et al. 1999 ) Gest. Age in weeks Vol. (L) 8.0
6.0
4.0
2.0
0 10 20 30 40 Total Blood Volume Plasma Volume Erythrocyte Volume Haemoglobin ( gr/dl ) during pregnancy ( From CDC 1989 ) Hb GESTATIONAL AGE (Weeks) 14
13
12
11
10 10 12 16 20 24 28 32 36 40 42 Low Limit of Normal ( 5 th Percentile ) For Hb and Hct during Pregnancy From CDC - 1989 Gestational Age ( Weeks ) 12 16 20 24 28 32 36 40
5 th Percentile of Hct 33 32 32 32 32 33 34 36 CHANGE IN HEMATOLOGICAL PARAMETERS DURING PREGNANCY PARAMETERS NONPREGNANT PREGNANT TOTAL BLOOD VOLUME 4000 ml 5200 ml
PLASMA VOLUME 2600 ml 3500 ml
ERYTHROCYTE VOLUME 1400 ml 1700 ml
HAEMOGLOBIN 12-16g/dl 11,5-13g/dl
HEMATOCRYT 37-44 % 34-41 % ( From Ramsay, 1999 ) COURSE OF HB VALUES IN HEALTHY PUERPERIUM DURING 14 DAYS ( From Richters, 1995 ) 13.5
13.0
12.5
12.0
11.5
11.0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Hb Days PP CHANGES IN ERYTHROCYTE COUNT, HB AND HCT IN NORMAL FETUSES ( From Forestier et al. 1991 ) GEST.AGE ERY COUNT HEMOGLOBIN HEMATOCRYT ( Weeks ) ( 1000.000/dl) (g/dl) ( % )
18-21 2,85 11,69 37,3
22-25 3,09 12,2 38,59
26-29 3,46 12,91 40,88
30 3,82 13,64 43,55 THE DEFINITION OF ANEMIA DURING PREGNANCY Hb. < 11.0 gr/dl ( During Pregnancy )
Hb. < 10.0 gr/dl ( During The PP periode ) REGARDLESS OF ITS CAUSE ( WHO 1972 ) 95 % OF ANEMIA DURING PREGNANCY
IRON DEFICIENCY ANEMIA THE PREVALENCE ANEMIA DURING PREGNANCY
80% Hb. 8 gr/dl
20% Hb. < 8 gr/dl
2-7% Hb. < 7 gr/dl GENERAL CONSEQUENCES OF ANEMIA DURING PREGNANCY
1. RISK OF ABNORMAL COURSE OF PREGNANCY 2. INCREASE MATERNAL AND INFANT MORBIDITY AND MORTALITY CLINICAL CONSEQUENCES REGARDLESS OF THE CAUSE OF THE ANEMIA
1. FATIGUE, EXHAUSTION, WEAKNESS, LESS OF ENERGY 2. CARDIOVASCULAR SYMPTOM - TACHYCARDIA - HYPOTENSION - CARDIAC HYPERTROPHY IN CHRONIC CASES 3. PALLOR ( PALE OF MUCOUS MEMBRANE OF CONJUNCTIVAE ) ADDITIONAL RISK
1. INFECTION 2. BLEEDING TENDENCIES MATERNAL RISK
FATIGUE, DECREASE OF PHYSICAL FITNESS CARDIOVACULAR SYMPTOM, PREDISPOSING TO INFECTION, RISK OF PERIPARTUM BLOOD LOSS, RISK OF IMPAIRED WOUND HEALING FOETAL RISK ( IF MATERNAL Hb < 9 gr/dl )
PRETERM BIRTH IUGR IUFD RISK OF IRON DEFICIENCY ANEMIA DURING PREGNANCY EFFECT ON THE PLACENTA
CHRONIC HYPOXIA INDUCE COMPENSATORY PLACENTAL MECHANISM ESPECIALLY ON ANGIOGENESIS. FINALLY THE RELATIONSHIP BETWEEN PLACENTA AND FETAL GROWTH INFLUENCES THE RISK OF DEVELOPING VARIOUS DISORDERS IN ADULTHOOD SUCH AS CARDIOVASCULAR DESEASES AND DIABETES MELLITUS
1. INCIDENCE OF IUGR 2X AT Hb. < 9 gr/dl
2. IUFD 3X AT Hb. < 8 gr/dl
3. RISK OF PRETERM BIRTH 60% AT Hb. < 9 gr/dl
4. ANEMIA ASSOCIATED WITH RR FOR PRETRM BIRTH OF 2,7 AND SMALL FOR GESTATIONAL AGE OF 3,5
5. ANEMIA ASSOCIATED WITH AN ODDS-RATIO OF 1,8 FOR PRETERM BIRTH BETWEEN 28-32 WEEKS.
6. IUGR AT Hb. < 8,5 gr/dl ON FERRITIN < 10 g/l ASSOCIATION BETWEEN HAEMOGLOBIN LEVELS AND FETAL RISK ACCORDING TO VAROUS AUTHORS
RARE
OCCUR IN WOMEN WITH - UNBALANCED DIET - MALABSORBTION - ALCOHOL ABUSE
NO SPECIFIK EFFECT ON THE FOETUS FETAL RISK DEPEND ON THE SEVERITY OF THE ANEMIA ITSELF FOLIC ACID DEFICIENCY ANEMIA
RARE
CAUSED BY : - DEFICIENCY OF INTRINSIC FACTORS - FOLLOWING GASTRIC SURGERY - SECONDARY TO MALABSORBTION
1. Cytokine Mediated inhibition of hematopoesis 2. Reduce of iron to the erythrocyte from RES 3. Increase breakdown of erythrocytes ( some microorganism use iron for their enzymatic reaction ) RENAL ANEMIA Perinatal Risk